These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16119576)

  • 41. Circles of exclusion: obstacles in access to health care services in Israel.
    Filc D
    Int J Health Serv; 2010; 40(4):699-717. PubMed ID: 21058539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The significance of private health insurance in future medical care].
    Leienbach V
    Versicherungsmedizin; 2006 Jun; 58(2):65-6. PubMed ID: 16800142
    [No Abstract]   [Full Text] [Related]  

  • 43. Risks and benefits of private health care: exploring physicians' views on private health care in Ho Chi Minh City, Vietnam.
    Lönnroth K; Thuong LM; Linh PD; Diwan V
    Health Policy; 1998 Aug; 45(2):81-97. PubMed ID: 10186226
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The coalition of health entrepreneurs and their proposals for the reform of the Brazilian health system: political and programmatic setbacks (2014-2018).
    Morais HMM; Oliveira RS; Vieira-da-Silva LM
    Cien Saude Colet; 2019 Dec; 24(12):4479-4488. PubMed ID: 31778498
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Australian health policy changes of 1999 and 2000: an evaluation.
    Hopkins S; Zweifel P
    Appl Health Econ Health Policy; 2005; 4(4):229-38. PubMed ID: 16466274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health care services in a new South Africa.
    Benatar SR; van Rensburg HC
    Hastings Cent Rep; 1995; 25(4):16-21. PubMed ID: 7591718
    [No Abstract]   [Full Text] [Related]  

  • 47. Welfarism versus 'free enterprise': considerations of power and justice in the Philippine healthcare system.
    Sy PA
    Bioethics; 2003 Oct; 17(5-6):555-66. PubMed ID: 14959725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The structure of South Africa's health service.
    Zwarenstein M
    Afr Health; 1994 Mar; (Spec No):3-4. PubMed ID: 12345506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Global development challenges and health care reform.
    Preker AS
    World Hosp Health Serv; 2001; 37(3):2-8, 40, 42. PubMed ID: 11858008
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The development of the nongovernmental public health sector in a transitional economy].
    Golukhov GN; Shilenko AIu; Shilenko IuV
    Probl Sotsialnoi Gig Istor Med; 1996; (6):25-31. PubMed ID: 9235265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Public sector and private sector alcoholism treatment. Economic competition or cooperation?
    De Miranda J
    Alcohol Health Res World; 1987; 12(1):40-3. PubMed ID: 10285599
    [No Abstract]   [Full Text] [Related]  

  • 52. The emergence of a health insurance system in a developing country: the case of South Korea.
    Cho S
    J Health Soc Behav; 1989 Dec; 30(4):467-71. PubMed ID: 2600387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Russian rehab.
    Possehl SR
    Hosp Health Netw; 1997 Nov; 71(21):42-4. PubMed ID: 9374617
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Physicians and corporations: a corporate transformation of American medicine?
    Casalino LP
    J Health Polit Policy Law; 2004; 29(4-5):869-83; discussion 1005-19. PubMed ID: 15602850
    [No Abstract]   [Full Text] [Related]  

  • 55. The politics of health care reforms in U.S. presidential elections.
    Navarro V
    Int J Health Serv; 2008; 38(4):597-606. PubMed ID: 19069282
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The public and private sectors in health: economic issues.
    Newbrander W; Parker D
    Int J Health Plann Manage; 1992 Jan; 7(1):37-49. PubMed ID: 10120538
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health without wealth? Costa Rica's health system under economic crisis.
    Morgan LM
    J Public Health Policy; 1987; 8(1):86-105. PubMed ID: 3108317
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What can be done about the private health sector in low-income countries?
    Mills A; Brugha R; Hanson K; McPake B
    Bull World Health Organ; 2002; 80(4):325-30. PubMed ID: 12075370
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of health biotechnology in developing countries: can private-sector players be the prime movers?
    Abuduxike G; Aljunid SM
    Biotechnol Adv; 2012; 30(6):1589-601. PubMed ID: 22617902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Switzerland.
    Zweifel P
    J Health Polit Policy Law; 2000 Oct; 25(5):937-44. PubMed ID: 11068738
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.